m 4 Biobank Alliance & m 4 Trial Service Center



Similar documents
Mayo Alliance for Clinical Trials

BIOBANK QUALITY. Office:

Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA

Professional Certificate in Primary Care Psychology

Medical Psychology Certificate Program Information

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

Future Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports.

Organization and Job Profile

THE BIOTECH & PHARMACEUTICAL INDUSTRY

Sheffield Kidney Institute. Planning a Clinical Trial

I. INTRODUCTION DEFINITIONS AND GENERAL PRINCIPLE

SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS

Contact. Laboratory for Clinical Trials Laboratoire des Essays Cliniques Laboratorio de Ensayos Clinicos

The Clinical Trials Process an educated patient s guide

Comprehensive Sample Management Solutions

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

Guidance for Industry

National Cancer Institute

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Diagnostic Tests. Brad Spring Director, Regulatory Affairs

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

The Role of the CRO in Effective Risk-Based Monitoring

Master of Science in Biomedical Sciences

DMPK: Experimentation & Data

Patient Handbook on Stem Cell Therapies

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Annex 7 Guidelines for the preparation of a contract research organization master file

IBCSG Tissue Bank Policy

GOVERNANCE AND THE EHR4CR INSTITUTE

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

Principal Investigator and Sub Investigator Responsibilities

Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR

Global healthcare solutions

Regulatory Issues in Genetic Testing and Targeted Drug Development

IS YOUR PROJECT HUMAN SUBJECTS RESEARCH. A Guide for Investigators. Jacksonville University Institutional Review Board DEFINING RESEARCH

Research Resources at Partners Hospitals

Strategies to Prepare for Meetings with the FDA. Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA

Commonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative

Physician Assistant Studies

Conditions for Accreditation as (Basic) Pharmacologist

General Clinical Research Center at Stony Brook

NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23)

Reflections on Establishing a Masters Degree in Research Biobanking. Cheryl Gillett King s Health Partners Cancer Biobank

Balancing Big Data for Security, Collaboration and Performance

SERVICES FOR. Devices and Combination Products

CTC Technology Readiness Levels

CLINICAL TRIALS: FOCUS VS. DRIVING EFFICIENCIES BLINDLY

STANDARD OPERATING POLICY AND PROCEDURE

Introduction to Clinical Research

To know more about Pharmacovigilance and Clinical Trials Data Management

Needs, Providing Solutions

Clinical Data Management Overview

Even we will get to use your product someday. Enough reason for us to deliver.

University of California, Irvine. (December 4, 2010, Sapporo, Japan)

Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

United States Small Business Administration Office of Hearings and Appeals

SAS Drug Development User Connections Conference 23-24Jan08

CTRNet Standard Operating Procedure Job Descriptions, Roles and Responsibilities

How To Get A Grant From Kinesis

Template for essential information to be provided for proposals including clinical trials / studies / investigations

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC

Master of Science in Vision Science and Investigative Ophthalmology MVSIO

LifeLines Cohort Study. Salome Scholtens, Manager Research Office

Specialty Lab and Immunological Testing Services

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009

Transforming relationships Unleashing innovation

ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs

RESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS

Voluntary Genomic Data Submissions at the U.S. FDA

Meeting Priorities of Biotech & Small Pharma Companies

MASTERS IN PUBLIC HEALTH (M.A.)

Product Lifecycle Management for the Pharmaceutical Industry

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group

TAKING PART IN CANCER TREATMENT RESEARCH STUDIES

Medical Device Solutions. Battelle. Applied Research Device Development Clinical Research Sustaining Engineering

Comprehensive Data Resource Introduction

Non-clinical development of biologics

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations

Annex A. Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework

Enrico Invernizzi Alessandra Grande

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015

No Page 1 of 5. Issue Date 4/21/2014

Summary of the role and operation of NHS Research Management Offices in England

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Regulatory Compliance

Jobbetegnelser for det nuværende job i branchen

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS

The Evolution of Data Management Job Models. in the Execution of Clinical Trials.

Transcription:

m 4 Biobank Alliance & m 4 Trial Service Center Services & Consulting in (non-)clinical development www.m4.de

m 4 Biobank Alliance Central Access to High Quality Human Biospecimens for R&D

The m 4 Biobank Alliance Cooperation Network One-stop Access to Samples of Different Biobanks Source: Department for Pathology, TUM Source: Fotolia The m 4 Biobank Alliance provides access to tissue samples (formalin fixed, fresh and frozen) and to blood samples. Source: Fotolia

SERVICES of the m 4 Biobank Alliance Our partner biobanks offer Archive of >20.000 tissue and blood based specimens, also matched Broad spectrum of indications Prospective collection according to the user s specifications Source: Department for Pathology, TUM Clinical and anamnetic data, follow up data on demand Analytical services The contact person at Bio M provides an all-round service Single project agreement for all partner-biobanks QA for uniform, high quality of samples and data Coordination of sample and data allocation Scientific and clinical consulting Compliance with high standards for ethics and privacy protection

m 4 Biobank Alliance & m 4 Trial Service Center Two Strong Partners for Successful Translation Through close collaboration, m 4 Biobank Alliance and m 4 Trial Service Center offer comprehensive resources for the translation of your project from preclinical to clinical development. www.m4.de/bba www.m4.de/tsc

m 4 Trial Service Center We guide your project from nonclinical to clinical development!

m 4 Trial Service Center (TSC) Our mission We navigate you through the translational development! clinical development nonclinical development Nonclinical development Nonclinical drug development stategies Study designs, planning & management Data review / gap analysis Regulatory documentation Trial preparation Project management Clinical trial protocol Regulatory documentation Consulting on demand Clinical trial Sponsor project management Integration of service providers and study sites Consutling on demand, e.g. regarding monitoring, etc.

Our approach Experienced consultants plus a strong network Consulting & resources for your project from a single source! Prof. U. Mansmann Regulatory Biostatistics CROs & Labs Clinicians & Clinical developers Early clinical trial facilities Study sites

m 4 Trial Service Center (TSC) Our team: Consultants with longstanding experience Dr. Anneliese Schneider 15+ years industry experience in drug discovery and nonclinical development Senior Expert in Tox, PK, PD (Board Certified) We are your local experts! Lena Mokelke, Dipl.-Biol. 10+ years industry experience in clinical trials Strong project management skills Dr. Martin Sippel Expertise in early drug development Project management and industry consulting experience

Selection of references Guidance and services for successful translational development Translational development (I): Comprehensive guidance in the preparation of a Phase I trial We provided advice on the preclinical programs required for the start of clinical development We established a roadmap to enter the clinical trial: Timelines, Roles & Responsibilities, The roadmap was put into practice by our experienced project manager Development and writing of the clinical trial protocol, with mulitdisciplinary input from our network of specialists We also involved service providers from our network Important: Long-term experience of our team to avoid pitfalls!

Selection of references Guidance and services for successful translational development Translational development (II): Early advice on preclinical & clinical development strategy Preclinical advice: Results from tox studies were assessed by our team expert By overseeing the whole development process, we assure that regulatory requirements are met Very important: Advice on clinical strategy involvement of experts for the relevant indications from our network

Selection of references Guidance and services for successful translational development Preclinical development: General assessment of preclinical program Overall assessment and data evaluation of preclinical safety & pharmacology studies Input by our experienced team expert: Verification of conclusions from preclinical data Advice and recommendations for further procedures in nonclinical development

Selection of references Guidance and services for successful translational development For advanced researchers: Our review service Example: clinical trial protocol optimization Our team expert for clinical development initiated study design optimizations during in-depths discussions In close cooperation with our biostatistics partner Prof. Mansmann, we adjusted the number of patients for sufficient statistical power. Also, we enhanced the clarity of trial procedures described in the protocol, leading to a more comprehensive description for study personnel potential for protocol violations is diminished!

Selection of references Guidance and services for successful translational development Other topics we advised upon Interaction with authorities Drug-drug interactions, DMPK for small molecules Validation of assays in Personalized Medicine: QM issues for laboratories (in close cooperation with QM experts from our network) Technical validation of assay Clinical validation strategy, trial preparation

Thank you! How can we support you? Get in touch with us! Dr. Martin Sippel Phone +49 (0)89 89 96 7937 Mail Web sippel@bio-m.org www.m4.de/tsc www.m4.de/bba